Oskar Ljungquist

Medicin och livsvetenskap

1. 16S Ribosomal RNA 31%
2. Acinetobacter 26%
3. Acinetobacter Infections 6%
4. Anaerobic Bacteria 8%
5. Aneurysm 11%
6. Anti-Bacterial Agents 7%
7. Antibodies 11%
8. Bacteremia 43%
9. beta-lactamase CTX-M-15 5%
10. beta-Lactamases 68%
11. Biopsy 13%
12. Blood Culture 11%
13. Blood Vessels 12%
14. Carbapenems 24%
15. Cephalosporins 26%
16. Ciprofloxacin 7%
17. Cohort Studies 19%
18. Convalescent Hospital 5%
19. Cross-Sectional Studies 16%
20. Diarrhea 17%
21. Dogs 15%
22. Enterobacteriaceae 47%
23. Escherichia coli 19%
24. Extraintestinal Pathogenic Escherichia coli 11%
25. fim 1 7%
26. galantide 30%
27. Genes 7%
28. Immunoglobulin G 16%
29. Immunosuppression 10%
30. Infections 28%
31. Meta-Analysis 16%
32. Mortality 21%
33. Observational Studies 36%
34. Oxygen 7%
35. Placebos 17%
36. Pleural Empyema 30%
37. Population 10%
38. Probiotics 22%
39. Prostate 17%
40. Randomized Controlled Trials 28%
41. Standard of Care 17%
42. Streptococcus pneumoniae 7%
43. Sweden 100%
44. Systematic Reviews 15%
45. Therapeutics 12%
46. Transplants 13%
47. Urinary Tract Infections 10%
48. Uropathogenic Escherichia coli 10%
49. Viridans Streptococci 10%
50. Whole Genome Sequencing 8%